Range
18.17 - 19.74
Vol / Avg.
955.3K/697K
Div / Yield
-
52 Wk
1.26 - 30.38
Mkt Cap
957.7M
Payout Ratio
-
Open
19.51
P/E
-
EPS
-0.57
Shares
52.1M
Outstanding
52.1M
Total Float
-
load more
Sector: Health Care.Industry: Pharmaceuticals
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from the contract research segment, which provides laboratory services. Its drug candidates under development are ATI-450, which is an Oral MK2 Inhibitor; ATI-2138 is an ITJ Inhibitor; and ATI-1777.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-06
REV
Q1 2021Est.ActualSurprise
EPS-0.290-0.570 -0.2800
REV1.690M1.777M87.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ACRSAclaris Therapeutics-6.46%957.7M

Aclaris Therapeutics Frequently Asked Questions

Q

How do I buy Aclaris Therapeutics (ACRS) stock?

A

You can purchase shares of Aclaris Therapeutics (NASDAQ: ACRS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aclaris Therapeutics's (ACRS) competitors?

Q

What is the target price for Aclaris Therapeutics (ACRS) stock?

A

The latest price target for Aclaris Therapeutics (NASDAQ: ACRS) was reported by HC Wainwright & Co. on April 21, 2021. The analyst firm set a price target for 40.00 expecting ACRS to rise to within 12 months (a possible 117.63% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Aclaris Therapeutics (ACRS)?

A

The stock price for Aclaris Therapeutics (NASDAQ: ACRS) is $18.38 last updated Fri Jun 11 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Aclaris Therapeutics (ACRS) pay a dividend?

A

There are no upcoming dividends for Aclaris Therapeutics.

Q

When is Aclaris Therapeutics (NASDAQ:ACRS) reporting earnings?

A
Aclaris Therapeutics’s Q2 earnings are confirmed for after-market on August 6, 2021.
Q

Is Aclaris Therapeutics (ACRS) going to split?

A

There is no upcoming split for Aclaris Therapeutics.

Q

What sector and industry does Aclaris Therapeutics (ACRS) operate in?

A

Aclaris Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.